Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. engages in the research and development, manufacture, and commercialization of novel drugs. The company is headquartered in Chengdu, Sichuan and currently employs 1,870 full-time employees. The company went IPO on 2023-07-11. The firm is mainly engaged in the research and development, manufacturing and commercialization of novel drugs in oncology, immunology and other therapeutic areas. The firm's products are antibody drug conjugates (ADCs) SKB264, A166 and others. The firm's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, gastrointestinal cancer and other diseases.
06990.HK stock price ended at $469.2 on Perşembe, after dropping 0.97%
On the latest trading day Jan 08, 2026, the stock price of 06990.HK fell by 0.97%, dropping from $473.80 to $469.20. During the session, the stock saw a volatility of 5.99%, with prices oscillating between a daily low of $457.60 and a high of $485.00. On the latest trading day, the trading volume for 06990.HK rose by 1.4M shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 2.7M shares were traded, with a market value of approximately $76.3B.
06990.HKTeknik Sinyalleri
Teknik Sinyaller Özeti
Satın Alma Sinyalleri 3
Nötr Sinyaller 0
Satış Sinyalleri 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
06990.HK, şu anda 3 alım sinyali ve 4 satım sinyali vermektedir. Hisse senedi 12:00 AM'ten beri Aşağı yönlü trend durumundadır ve bu dönemde toplam -0.97% fiyat değişimi gerçekleşti. Genel olarak teknik göstergeler orta vadeli olarak Sell görünüm işaret etmektedir.
06990.HK için Boğa/Ayı Sinyalleri
Hareketli ortalamalar, RSI, MACD ve işlem hacmi gibi temel göstergeleri analiz ederek 06990.HK için yükseliş ve düşüş sinyalleri üretiyoruz. Bu analizlerle daha bilinçli yatırım kararları verin.